- Support for study design made available 2018-10-29
- 15.000 patients included in U-CAN 2018-03-29
- Increased number of applications for U-CAN samples in 2017 2017-12-22
- Statistics for patients included in U-CAN in the Uppsala-Örebro region 2017-11-24
- New U-CAN diagnoses in Uppsala: Esophagus and stomach cancer 2017-07-03
Number of patients
Until the end of June 2018
16.500 patients had been included in U-CAN.
Access U-CAN material
U-CAN collects blood and tissues samples, and clinical information from cancer patients.
This is U-CAN
Four universities participate in U-CAN
Cancer includes more than two hundred diseases that are all caused by uncontrolled cell growth. In the last decades the number of cancer patients that are cured has increased. However, cancer therapies are unfortunately complicated by the fact that the diseases are very complex and can take different courses in different patients. It is therefore important that future therapy is adapted to the disease of the individual cancer patient.
In U-CAN we collect and organise patient samples that are taken before, during and after cancer therapy. Patient data and radiological images are also collected. We use this material to develop methods to fine tune diagnoses and to better characterise different tumour diseases, in order to be able to choose an optimal therapy for the individual patient. We will also develop and evaluate new medicines and other treatment strategies, and examine why therapies are efficient or not.
The research paper U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden presents U-CAN's activities during the first five years.